Vowst Market Report 2026

Vowst Market Overview

• The Vowst market growth in the historic period has been driven by increasing incidence of recurrent C. diff infections, limitations of traditional antibiotic therapies • Market expansion is supported by expansion of microbiome-based drug development, rising demand for non-antibiotic infection management • Growth Driver: Rising Prevalence Of Clostridioides Difficile Infections And Their Impact On Treatment Options • Market Trend: Advancing Microbiome-Based Therapies For Recurrent Clostridioides Difficile Infections • North America was the largest region in 2025.

What Is Covered Under Vowst Market?

Vowst is a prescription medication containing live fecal microbiota spores, designed to prevent the recurrence of clostridioides difficile (C. diff) infections in adults after antibiotic treatment. It works by restoring beneficial gut bacteria, thereby inhibiting C. diff's ability to proliferate and cause infection again. The main indications in the vowst market are infectious diseases, gut microbiota restoration, and immune modulation. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that invade the body and can spread directly or indirectly between individuals. The various distribution channels include hospitals, specialty pharmacies, retail pharmacies, and online pharmacies, and several end users including adult and geriatric.

What Is The Vowst Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of microbiome-based drug development, rising demand for non-antibiotic infection management, increasing investment in gut health research, growing adoption of precision microbiome therapies, advancements in oral biologic formulation technologies. Major trends in the forecast period include increasing adoption of microbiota-based therapeutics, rising focus on gut microbiome restoration therapies, growing use of oral live biotherapeutic products, expansion of targeted infection recurrence prevention, enhanced emphasis on antibiotic-adjunct treatments.

Global Vowst Market Segmentation

1) By Indication: Infectious Diseases, Gut Microbiota Restoration, Immune Modulation 2) By Distribution Channel: Hospitals, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies 3) By End User: Adult, Geriatric

What Is The Driver Of The Vowst Market?

Increasing prevalence of clostridioides difficile infections is expected to propel the growth of the vowst market going forward. Clostridioides difficile infections (CDIs) refer to illnesses caused by the bacterium Clostridioides difficile, which typically result in inflammation of the colon, leading to symptoms such as severe diarrhea, abdominal pain, and fever. Clostridioides difficile infections (CDI) are driven by factors such as widespread antibiotic use disrupting gut microbiota, increased prevalence of healthcare-associated infections, aging populations with weakened immune systems, and the rise of hypervirulent C. difficile strains. Vowst helps treat clostridioides difficile infections (CDI) by restoring the natural balance of bacteria in the gut, which is often disrupted by antibiotics. For instance in March 2023 accroding to the The National Library of Medicine (NLM) a US-based biomedical library Clostridioides difficile infection (CDI) impacts roughly 500,000 individuals each year in the United States, with about 30,000 of these cases resulting in death. Therefore, the increasing prevalence of clostridioides difficile infections is driving the growth of the vowst industry.

Key Players In The Global Vowst Market

Major companies operating in the vowst market are Seres Therapeutics Inc.

Global Vowst Market Trends and Insights

The key trend in the Vowst market is focusing on developing innovative products, such as antibacterial treatments for recurrent clostridioides difficile infection (rCDI), to address the growing need for effective therapies, improve patient outcomes, and reduce the risk of infection recurrence. Antibacterial treatments for recurrent Clostridioides difficile infection refer to specialized therapeutic interventions designed to target and eliminate C. difficile bacteria in patients experiencing repeated episodes of infection. For instance, in April 2023, Seres Therapeutics Inc., a US-based biotech company, and Nestlé Health Science, a Switzerland-based pharmaceutical company, received United States Food and Drug Administration (FDA) approval of Vowst (fecal microbiota spores, live-brpk), an orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI (rCDI). It is designed to restore a healthy gut microbiome and reduce the likelihood of recurrence after initial treatment.

What Are Latest Mergers And Acquisitions In The Vowst Market?

In August 2024, Nestlé Health Science, a Switzerland-based pharmaceutical company, signed an asset purchase agreement with Seres Therapeutics for its VOWST business for $175 million. The acquisition aims to enable Nestlé Health Science to gain full control of the vowst business, enhancing its capabilities in the microbiome therapeutics space and strengthening its portfolio of innovative treatments for gastrointestinal health, including the prevention of recurrent clostridioides difficile infections (CDI). Seres Therapeutics Inc. is a US-based company, developing vowst.

Regional Insights

North America was the largest region in the vowst market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Vowst Market?

The vowst market consists of sales of vowst capsules, microbiome diagnostics kits, gut health supplements, and fecal microbiota transplant (FMT) alternatives. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vowst Market Report 2026?

The vowst market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vowst industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.